A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2007
11/08/2007	US20070259807 Growth Factor HTTER36
11/08/2007	US20070259419 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis
11/08/2007	US20070259400 Antibodies
11/08/2007	US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007	US20070259379 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity
11/08/2007	US20070259358 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
11/08/2007	US20070259352 miRNA for diagnosis, prognosis, and treatment of prostate cancer; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis
11/08/2007	US20070259350 Liver cancer-related nucleic acids
11/08/2007	US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007	US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007	US20070258991 Immunogenic agent therapy using plasmapheresis
11/08/2007	US20070258985 Human mini-antibody cytotoxic for tumor cells which express the ERB-B2 receptor
11/08/2007	US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007	US20070258965 Method to Improve Lactococcus Preservation
11/08/2007	US20070258962 Plasmid comprising murine cytomegalovirus intermediate early 2 (mCMV-IE2) promoter for enhancing heterologous gene transcription; gene therapy and genetic engineering
11/08/2007	US20070258961 Cholesterol efflux and uses thereof
11/08/2007	US20070258952 Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
11/08/2007	US20070258951 Methods of treating cardiac disorders
11/08/2007	US20070258950 Methods and compositions for recovering or improving visual function
11/08/2007	US20070258949 Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/08/2007	US20070258944 Multiple cytokine protein complexes
11/08/2007	US20070258943 Genetically engineered cells for therapeutic applications
11/08/2007	US20070258901 Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
11/08/2007	US20070258897 Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells
11/08/2007	DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007	CA2650270A1 High-titer retroviral packaging cells
11/08/2007	CA2648064A1 Regulated expression of recombinant proteins from adeno-associated viral vectors
11/07/2007	EP1852511A1 Bovine immunodeficiency virus (biv) based vectors
11/07/2007	EP1852505A1 Mutations in ion channels
11/07/2007	EP1852503A1 Il-13 production inhibitor
11/07/2007	EP1852178A1 Process for producing coated fine particle
11/07/2007	EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007	EP1852123A2 Activation and inhibition of the immune system
11/07/2007	EP1851307A1 Method of treatment by administration of rna
11/07/2007	EP1851240A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
11/07/2007	EP1851239A1 Replication-deficient rna viruses as vaccines
11/07/2007	EP1850879A1 Method of genotypically modifying cells by administration of rna
11/07/2007	EP1850658A2 Improved modalities for the treatment of degenerative diseases of the retina
11/07/2007	EP1565578A4 Rnai-based sensors, caged interfering rnas, and methods of use thereof
11/07/2007	EP0572401B2 Viral particles having altered host range
11/07/2007	CN101068927A Methods and compositions to inhibit p2x7 receptor expression
11/07/2007	CN101068575A Methods for targeted delivery of genetic material to the liver
11/07/2007	CN101068574A Specific inhibition of autoimmunity and diseases associated with autoantigens
11/07/2007	CN101067139A RNAi vector and its application
11/07/2007	CN101067135A Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/07/2007	CN101066465A Antitumor use of antisense thionucleotide
11/07/2007	CN101066464A Streptococcus DNA vaccine pcDNA3.1 GapC and its prepn process
11/07/2007	CN101066463A Staphylococcus aureau DNA vaccine pcDNA3.1(+)-Minigene and its prepn process
11/07/2007	CN100347307C Recombination chimeric molecule Cb1-Grb2(SH2)-RING eukaryotic expression plasmid and antitumor genetic medicine use
11/07/2007	CN100347299C GATA-2 mutator as one of leukemia rapid change major genes and its use
11/07/2007	CN100346834C Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
11/07/2007	CN100346833C Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/07/2007	CN100346826C Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
11/06/2007	US7291723 Hepatitis G viral sequences for use as heterologous gene transfer tool; vaccine development; viricides
11/06/2007	US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007	US7291673 Polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups
11/06/2007	US7291605 Methods of treating various cancers using melanoma differentiation associated protein-7
11/06/2007	US7291604 Administering to tissue, such as blood vessel and active nucleic acids ; insertion of stents; cardiovascular disorders
11/06/2007	US7291597 Growth factor therapy mobilization of stem cells into the peripheral blood
11/06/2007	US7291498 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
11/06/2007	US7291495 β-Secretase variant
11/06/2007	US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening
11/06/2007	US7291452 Erythrovirus and its applications
11/06/2007	US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007	US7291330 MD-1 inhibitors as immune suppressants
11/06/2007	US7291325 Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins
11/06/2007	CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007	CA2271388C Liposomes encapsulating polynucleotides operatively coding for immunogenic polypeptides
11/06/2007	CA2113089C Universal donor cells
11/06/2007	CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/01/2007	WO2007124452A2 Methods for expressing multiple sirna and shrna from a single vector
11/01/2007	WO2007124198A2 Biopolymer system for tissue sealing
11/01/2007	WO2007124148A2 Treatment of connective tissue disorders
11/01/2007	WO2007124106A2 Application of antl-apoptotic genes in mammalian cells for perfusion culture.
11/01/2007	WO2007124096A2 Lrrk2 regulaton of neuronal process morphology
11/01/2007	WO2007123697A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
11/01/2007	WO2007123680A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/01/2007	WO2007123233A1 Gene associated with arteriosclerotic disease, and use thereof
11/01/2007	WO2007123010A1 Agent for improving bone metabolism
11/01/2007	WO2007122976A1 Therapeutic agent or development inhibitor of polyglutamine disease
11/01/2007	WO2007122823A1 Tumor target cell capable of producing vector
11/01/2007	WO2007122369A2 Novel tumour suppressor
11/01/2007	WO2007059473A3 Methods for the production and purification of adenoviral vectors
11/01/2007	WO2006102272A8 Methods for treating tumors and cancerous tissues
11/01/2007	WO2006083183A9 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting)
11/01/2007	WO2006083182A9 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease
11/01/2007	WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007	US20070255041 Bioengineered Vehicles for Targeted Nucleic Acid Delivery
11/01/2007	US20070254853 Compositions and Methods for Promotion of Wound Healing
11/01/2007	US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007	US20070254850 Methods for Treating and Preventing Apoptosis-Related Diseases Using Rna Interfering Agents
11/01/2007	US20070254845 Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53
11/01/2007	US20070254840 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides
11/01/2007	US20070254831 PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn
11/01/2007	US20070254830 Interaction of Colon Cancer Related Gene C200RF20 With P120
11/01/2007	US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007	US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007	US20070253971 Circovirus sequences associated with piglet weight loss disease (PWD)
11/01/2007	US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007	US20070253955 Methods for altering fertility

1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 870